ACTIVE

MED-PHARMA

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

27,9 k €

-9.7% YoY

Gross margin

30,5 k €

-32.5% YoY

Equity

743,3 k €

+3.9% YoY

What does MED-PHARMA do?

MED-PHARMA is a Private company with limited liability incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0818.652.680

Incorporation

18/09/2009

Legal form

Private company with limited liability

Registered office

Rue Eloy 86A
1070 Anderlecht · BruxellesSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2024

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010
Income statement
Gross margin	30,5 k €	-32.5%	45,2 k €	-10.4%	50,4 k €	+8.4%	46,5 k €	-12.5%	53,1 k €	-14.8%	62,4 k €	+15.4%	54,1 k €	-1.9%	55,1 k €	+250%	15,8 k €	-71.6%	55,5 k €	-8.8%	60,8 k €	+8.4%	56,1 k €	-4.5%	58,7 k €	-23.8%	77 k €	+27.4%	60,5 k €
EBITDA	29,3 k €	-33.3%	43,9 k €	-10.8%	49,2 k €	+7.9%	45,6 k €	-10.8%	51,2 k €	+8.4%	47,2 k €	-7.3%	51 k €	-0.0%	51 k €	+253%	14,4 k €	-73.4%	54,2 k €	-9.3%	59,7 k €	+7.7%	55,5 k €	-3.5%	57,5 k €	-24.7%	76,3 k €	+27.7%	59,8 k €
Operating result	28,8 k €	-33.5%	43,4 k €	-10.5%	48,5 k €	+8.0%	44,9 k €	-11.2%	50,5 k €	+12.1%	45,1 k €	-7.3%	48,6 k €	+0.2%	48,5 k €	+297%	12,2 k €	-76.5%	52 k €	-12.6%	59,5 k €	+7.8%	55,2 k €	-3.5%	57,2 k €	-24.8%	76 k €	+29.6%	58,7 k €
Net result	27,9 k €	-9.7%	30,9 k €	+4.3%	29,6 k €	-3.3%	30,6 k €	-6.7%	32,8 k €	+61.9%	20,2 k €	-10.8%	22,7 k €	-38.7%	37 k €	+317%	8,9 k €	-72.5%	32,2 k €	-2.0%	32,9 k €	+8.9%	30,2 k €	+16.2%	26 k €	-32.6%	38,6 k €	-89.0%	349,5 k €
Balance sheet
Equity	743,3 k €	+3.9%	715,4 k €	+4.5%	684,6 k €	+4.5%	655 k €	+4.9%	624,4 k €	+5.5%	591,7 k €	+3.5%	571,4 k €	+4.1%	548,7 k €	+7.2%	511,7 k €	+1.8%	502,8 k €	+6.9%	470,6 k €	+5.4%	446,7 k €	+4.7%	426,4 k €	+6.5%	400,4 k €	+10.7%	361,9 k €
Total assets	983,9 k €	+2.9%	956,3 k €	+5.4%	907,4 k €	+2.1%	888,7 k €	+3.1%	862 k €	+2.1%	844 k €	-2.5%	865,9 k €	+1.7%	851,4 k €	+0.7%	845,2 k €	+4.7%	807,4 k €	-3.9%	840,6 k €	-0.2%	842,3 k €	-2.7%	865,7 k €	-4.1%	902,9 k €	+2.1%	884,6 k €
Cash	–		91 €		–		–		840 €	-88.9%	7,5 k €	-1.4%	7,6 k €	+119%	3,5 k €	-23.4%	4,6 k €	-29.8%	6,5 k €	-49.1%	12,8 k €	-23.3%	16,6 k €	+221%	5,2 k €	-63.9%	14,3 k €	+129%	6,3 k €
Debts	239,7 k €	-0.5%	240,9 k €	+8.1%	222,9 k €	-4.6%	233,7 k €	-1.6%	237,5 k €	-5.9%	252,3 k €	-14.3%	294,5 k €	-2.7%	302,7 k €	-9.0%	332,6 k €	+9.2%	304,6 k €	-15.5%	360,5 k €	-7.8%	391,1 k €	-10.0%	434,7 k €	-13.5%	502,5 k €	-3.9%	522,8 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

HIND RAHALI

Managing director

Active

Ended mandates

Hind RAHALI

Manager · since 16 septembre 2009

Ended

Hind Rahali

Mandate

Ended

Hind Rahali

Manager

Ended

HIND RAHALI

Director

Ended

At this address

Other companies at this address

Company	CBE no.
PHARMACIE DELEM● Active	0436.965.303

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/09/2025	05/11/2024	24/10/2023	29/10/2022	28/10/2021	30/11/2020
General meeting	16/06/2025	17/06/2024	19/06/2023	20/06/2022	26/10/2021	13/11/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

15 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	16/06/2025	30/09/2025	French	PDF
Micro model	31/12/2023	17/06/2024	05/11/2024	French	PDF
Micro model	31/12/2022	19/06/2023	24/10/2023	French	PDF
Micro model	31/12/2021	20/06/2022	29/10/2022	French	PDF
Micro model	31/12/2020	26/10/2021	28/10/2021	French	PDF
Micro model	31/12/2019	13/11/2020	30/11/2020	French	PDF
Micro model	31/12/2018	17/06/2019	15/10/2019	French	PDF
Micro model	31/12/2017	30/06/2018	31/08/2018	French	PDF
Abridged model	31/12/2016	20/06/2017	31/08/2017	French	PDF
Abridged model	31/12/2015	30/08/2016	31/08/2016	French	PDF
Abridged model	31/12/2014	15/06/2015	29/09/2015	French	PDF
Abridged model	31/12/2013	16/06/2014	11/09/2014	French	PDF
Abridged model	31/12/2012	17/06/2013	19/07/2013	French	PDF
Abridged model	31/12/2011	18/06/2012	29/08/2012	French	PDF
Abridged model	31/12/2010	20/06/2011	30/08/2011	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

HIND RAHALI

Managing director

Active

Ended mandates

Hind RAHALI

Manager · since 16 septembre 2009

Ended

Hind Rahali

Mandate

Ended

Hind Rahali

Manager

Ended

HIND RAHALI

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other29/09/2009
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202427,9 k €↓
2023
Annual accounts 202330,9 k €↑
2022
Annual accounts 202229,6 k €↓
2021
Annual accounts 202130,6 k €↓
2020
Annual accounts 202032,8 k €↑
2019
Annual accounts 201920,2 k €↓
2018
Annual accounts 201822,7 k €↓
2017
Annual accounts 201737 k €↑
2016
Annual accounts 20168,9 k €↓
2015
Annual accounts 201532,2 k €↓
2014
Annual accounts 201432,9 k €↑
2013
Annual accounts 201330,2 k €↑
2012
Annual accounts 201226 k €↓
2011
Annual accounts 201138,6 k €↓
2010
Annual accounts 2010349,5 k €
18/09/2009
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MED-PHARMA

Overview

What does MED-PHARMA do?

Trend over 15 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline